53. Sjogren syndrome Clinical trials / Disease details

Clinical trials : 305 / Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04909255 (ClinicalTrials.gov)	March 23, 2021	21/4/2021	Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder	The Therapeutic Effect of Beta-3 Agonist and Anti-muscarinic Agent on Overactive Bladder Among Sjogr ...	Sjogren's Syndrome;Overactive Bladder Syndrome	Drug: mirabegron;Drug: oxybutynin , tolterodine, solifenacin	China Medical University Hospital	NULL	Recruiting	20 Years	N/A	All	50	Phase 4	Taiwan

First Previous1Next Last